Influence of glucocorticoid substances and the vehicle on skin irritancy: determination by profilometry.
Korting
H C
HC
Dermatologische Klinik und Poliklinik, Ludwig-Maximilians-Universität München, BRD.
D000279:Administration, Cutaneous; D001624:Betamethasone Valerate / Q000008:administration & dosage / Q000009:adverse effects; D002990:Clobetasol / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D004311:Double-Blind Method; D003875:Drug Eruptions / Q000209:etiology*; D004655:Emulsions / Q000008:administration & dosage / Q000009:adverse effects; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D014677:Pharmaceutical Vehicles / Q000008:administration & dosage / Q000009:adverse effects*; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D012826:Silicone Elastomers; D012867:Skin / Q000187:drug effects* / Q000473:pathology; D017443:Skin Diseases, Eczematous / Q000139:chemically induced*; D013499:Surface Properties; D013684:Telangiectasis / Q000139:chemically induced*; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000009:adverse effects
D004655:Emulsions; D005938:Glucocorticoids; D014677:Pharmaceutical Vehicles; D012826:Silicone Elastomers; D001624:Betamethasone Valerate; D011239:Prednisolone; D002990:Clobetasol; D014222:Triamcinolone Acetonide; C035287:prednicarbate